title: Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance.
abstract: With the need for healthcare cost-containment, increased scrutiny will be placed on new medical therapeutic or diagnostic technologies. Several challenges exist for a new diagnostic test to demonstrate cost-effectiveness. New diagnostic tests differ from therapeutic procedures due to the fact that diagnostic tests do not generally directly affect long-term patient outcomes. Instead, the results of diagnostic tests can influence management decisions for patients and by this route, diagnostic tests indirectly affect long-term outcomes. The benefits from a specific diagnostic technology depend therefore not only on its performance characteristics, but also on other factors such as prevalence of disease, and effectiveness of existing treatments for the disease of interest. We review the concepts and theories of cost-effectiveness analyses (CEA) as they apply to diagnostic tests in general. The limitations of CEA across different study designs and geographic regions are discussed, and we also examine the strengths and weakness of the existing publications where CMR was the focus of CEA compared to other diagnostic options.
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Cardiovascular Division, Boston, MA, USA.
authors.forename: Sanjeev A
authors.initials: SA
authors.lastname: Francis
authors.forename: Caroline
authors.initials: C
authors.lastname: Daly
authors.forename: Bobak
authors.initials: B
authors.lastname: Heydari
authors.forename: Siddique
authors.initials: S
authors.lastname: Abbasi
authors.forename: Ravi V
authors.initials: RV
authors.lastname: Shah
authors.forename: Raymond Y
authors.initials: RY
authors.lastname: Kwong
mesh_terms: D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000191:economics*; D013673:Technology Assessment, Biomedical / Q000191:economics*